Cargando…
Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
BACKGROUND: Increasing evidence has indicated immune-related genes (IRGs) play a key role in the development of hepatocellular carcinoma (HCC). Whereas, there have been no investigations proposing a reliable prognostic signature in terms of IRGs. This study aimed to develop a robust signature based...
Autores principales: | Liu, Zaoqu, Jiao, Dechao, Liu, Long, Zhou, Xueliang, Yao, Yuan, Li, Zhaonan, Li, Jing, Chen, Jianjian, Lei, Qinyu, Han, Xinwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969274/ https://www.ncbi.nlm.nih.gov/pubmed/33725827 http://dx.doi.org/10.1097/MD.0000000000024683 |
Ejemplares similares
-
Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management
por: Liu, Zaoqu, et al.
Publicado: (2021) -
Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2021) -
Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments
por: Yao, Yuan, et al.
Publicado: (2020) -
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021) -
The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)